Source:http://linkedlifedata.com/resource/pubmed/id/10073183
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-3-24
|
pubmed:abstractText |
Fulminant hepatic failure is a disease of varied causes and a high mortality rate. A sudden onset, jaundice, hepatic encephalopathy, and multiorgan failure are the hallmarks of this syndrome. The management of patients with FHF requires a multidisciplinary approach and intense monitoring. The availability of liver transplantation has provided the means to rescue such patients from near-certain death. Early prognostication and timely availability of donor livers are requirements for a successful outcome. The development of effective artificial liver support devices may greatly prolong the window of opportunity to provide a donor liver, or alternatively, to allow the native liver to regenerate.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0039-6109
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-108
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10073183-Acetaminophen,
pubmed-meshheading:10073183-Amanita,
pubmed-meshheading:10073183-Analgesics, Non-Narcotic,
pubmed-meshheading:10073183-Hepatic Encephalopathy,
pubmed-meshheading:10073183-Humans,
pubmed-meshheading:10073183-Liver Transplantation,
pubmed-meshheading:10073183-Monitoring, Physiologic
|
pubmed:year |
1999
|
pubmed:articleTitle |
Fulminant hepatic failure.
|
pubmed:affiliation |
Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA. obaid@med.pitt.edu
|
pubmed:publicationType |
Journal Article,
Review
|